Literature DB >> 27307291

Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?

Yuguo Xia1, Wei Cai1, Angus W Thomson2, Xiaoming Hu3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27307291      PMCID： PMC5179138          DOI： 10.1007/s12975-016-0476-4

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  60 in total

1.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

Authors:  Dela Golshayan; Shuiping Jiang; Julia Tsang; Marina I Garin; Christian Mottet; Robert I Lechler
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

Review 2.  Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.

Authors:  Piotr Trzonkowski; Magdalena Szaryńska; Jolanta Myśliwska; Andrzej Myśliwski
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

3.  CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Metab Brain Dis       Date:  2010-11-17       Impact factor: 3.584

Review 4.  Functional role of regulatory lymphocytes in stroke: facts and controversies.

Authors:  Arthur Liesz; Xiaoming Hu; Christoph Kleinschnitz; Halina Offner
Journal:  Stroke       Date:  2015-03-19       Impact factor: 7.914

5.  Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Authors:  Keli L Hippen; Sarah C Merkel; Dawn K Schirm; Christine M Sieben; Darin Sumstad; Diane M Kadidlo; David H McKenna; Jonathan S Bromberg; Bruce L Levine; James L Riley; Carl H June; Phillip Scheinberg; Daniel C Douek; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

6.  Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.

Authors:  Peiying Li; Leilei Mao; Xiangrong Liu; Yu Gan; Jing Zheng; Angus W Thomson; Yanqin Gao; Jun Chen; Xiaoming Hu
Journal:  Stroke       Date:  2014-02-04       Impact factor: 7.914

Review 7.  Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Authors:  Adviye Ergul; Sherif Hafez; Abdelrahman Fouda; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2016-03-30       Impact factor: 6.829

Review 8.  Molecular and cellular immune responses to ischemic brain injury.

Authors:  Hilary A Seifert; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-06-05       Impact factor: 6.829

Review 9.  Application of IL-2 therapy to target T regulatory cell function.

Authors:  Ethan M Shevach
Journal:  Trends Immunol       Date:  2012-08-30       Impact factor: 16.687

10.  The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues.

Authors:  Claudia Waskow; Kang Liu; Guillaume Darrasse-Jèze; Pierre Guermonprez; Florent Ginhoux; Miriam Merad; Tamara Shengelia; Kaihui Yao; Michel Nussenzweig
Journal:  Nat Immunol       Date:  2008-05-11       Impact factor: 25.606
View more
  16 in total

1.  Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke.

Authors:  Elliot G Neal; Sandra A Acosta; Yuji Kaneko; Xunming Ji; Cesario V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-23       Impact factor: 6.200

2.  Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.

Authors:  Fang Zhang; Chen Yan; Changjuan Wei; Yang Yao; Xiaofeng Ma; Zhongying Gong; Shoufeng Liu; Dawei Zang; Jieli Chen; Fu-Dong Shi; Junwei Hao
Journal:  Transl Stroke Res       Date:  2017-07-09       Impact factor: 6.829

3.  Correcting the Trajectory of Stroke Therapeutic Research.

Authors:  Keith R Pennypacker; Gregory Bix; Justin F Fraser
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

Review 4.  Regulatory T cells in ischemic stroke.

Authors:  Hong-Yun Wang; Jun-Rui Ye; Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 6.150

Review 5.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 6.  Engineering of Immune Microenvironment for Enhanced Tissue Remodeling.

Authors:  Ga Ryang Ko; Jung Seung Lee
Journal:  Tissue Eng Regen Med       Date:  2022-01-18       Impact factor: 4.169

7.  The role of regulatory T cells in the regulation of upper airway inflammation.

Authors:  Charlie Palmer; Jennifer K Mulligan; Sarah E Smith; Carl Atkinson
Journal:  Am J Rhinol Allergy       Date:  2017-11-01       Impact factor: 2.300

8.  BMP4/LIF or RA/Forskolin Suppresses the Proliferation of Neural Stem Cells Derived from Adult Monkey Brain.

Authors:  Xinxin Han; Liming Yu; Qingqing Chen; Min Wang; Jie Ren; Guangming Wang; Yihong Chen; Lixia Lu; Haibin Tian; Li Chen; Ying Zhang; Yuehua Liu; Hua He; Zhengliang Gao
Journal:  Stem Cells Int       Date:  2017-09-20       Impact factor: 5.443

Review 9.  Neuroprotective Effects of Stem Cells in Ischemic Stroke.

Authors:  Weilin Xu; Jingwei Zheng; Liansheng Gao; Tao Li; Jianmin Zhang; Anwen Shao
Journal:  Stem Cells Int       Date:  2017-07-03       Impact factor: 5.443

Review 10.  Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.

Authors:  Marialuisa Gandolfi; Nicola Smania; Antonio Vella; Alessandro Picelli; Salvatore Chirumbolo
Journal:  Neural Plast       Date:  2017-03-08       Impact factor: 3.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.